GOLETA, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today reported financial results for its second quarter of fiscal 2026 ended December 31, 2025.

Management Commentary

“The second quarter marked another big step forward for Aeluma as we gear up for commercialization,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. “We ramped engagements across our target markets and increased visibility at a major industry conference. We are experiencing growing and sustained interest in Aeluma as our technology takes shape and market demand increases across mobile, data centers, and defense.”

“During the quarter, we continued to increase operations with foundry partners and are delighted with the performance, quality, and yield of wafers being tested at Aeluma’s facility,” Klamkin continued. “Relationships with customers and partners are strengthening, and we are fortunate that Bouch Nessar, our new Senior Vice President of Business Development and Product, has joined at this pivotal time to accelerate our go-to-market plan. Our IP portfolio also continues to expand, now counting 35 issued and pending patents, with our most recent application related to large-scale manufacturing of high-performance semiconductors.”

Klamkin concluded, “We are receiving increasing requests for price quotations and have begun taking sales orders. While these initial orders are relatively small in value, this marks an important milestone toward broader market adoption. As we move through fiscal 2026, we are intensely focused on commercialization and building long-term value.”

Recent Company Highlights

Fiscal Q2 2026 Financial Results

Fiscal Year 2026 Guidance and Strategic Priorities

For the full fiscal year of 2026, based on current and anticipated market conditions, Aeluma continues to expect revenue in a range of $4.0 million to $6.0 million. The following reaffirms the Company’s strategic priorities for 2026:

Conference Call and Webcast

Aeluma will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on February 11, 2026, to discuss the Company’s financial results and business outlook. Interested participants may access the conference the call by dialing (877) 317-6789 (domestic) or (412) 317-6789 (international) and referencing “Aeluma.”

A live webcast of the call will be available on the “Investors” section of Aeluma’s website and can also be accessed by clicking here. A replay of the conference call will be available on Aeluma’s website shortly after the call concludes.

Note about Non-GAAP Financial Measures

This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma's ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma's results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.

This press release includes non-GAAP financial measures, including:

A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

About Aeluma, Inc.

Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.

Company:

Aeluma, Inc.
(805) 351-2707
info@aeluma.com

Investor Contact:

Financial Profiles, Inc.
Moira Conlon & Alex Villalta
(310) 622-8227
ir@aeluma.com

Aeluma, Inc. and Subsidiary
Condensed Consolidated Balance Sheets

($ in thousands)   December 31,
2025
(unaudited)
    June 30,
2025
 
Assets            
Current assets:            
Cash and cash equivalents   $ 38,572     $ 3,628  
Certificate of deposit             12,112  
Accounts receivable     1,000       962  
Prepaids and other current assets     691       633  
Total current assets     40,263       17,335  
Property and equipment:                
Equipment     1,933       1,692  
Leasehold improvements     547       547  
Accumulated depreciation     (1,229 )     (1,021 )
Property and equipment, net     1,251       1,218  
Right of use asset - operating     1,033       836  
Other assets     23       17  
Total assets   $ 42,570     $ 19,406  
                 
Liabilities and stockholders' equity                
Current liabilities:                
Accounts payable   $ 184     $ 361  
Accrued expenses and other current liabilities     449       206  
Lease liability - operating, current portion     192       138  
Total current liabilities     825       705  
Lease liability - operating, long-term portion     942       803  
Total liabilities     1,767       1,508  
Commitments and contingencies     -       -  
Stockholders’ equity:                
Preferred stock     -       -  
Common stock     2       2  
Additional paid-in capital     60,793       34,542  
Accumulated deficit     (19,992 )     (16,646 )
Total stockholders’ equity     40,803       17,898  
Total liabilities and stockholders’ equity   $ 42,570     $ 19,406  


Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Operations (unaudited)

    Three Months Ended     Six Months Ended  
($ in thousands, except per share data)   December 31,
2025
    September 30,
2025
    December 31,
2024
    December 31,
2025
    December 31,
2024
 
Revenue   $ 1,272     $ 1,385     $ 1,612     $ 2,657     $ 2,093  
Operating expenses:                                        
Cost of goods sold     919       701       584       1,620       899  
Research and development             606       268       1,512       669  
General and administrative     1,528       1,686       371       3,214       867  
Total operating expenses     3,353       2,993       1,223       6,346       2,435  
Income (loss) from operations     (2,081 )     (1,608 )     389       (3,689 )     (342 )
Other income (expense):                                        
Interest income     228       115       -       343       -  
Amortization of discount on convertible notes     -       -       (283     -       (428
Changes in fair value of derivative liabilities     -       -       (3,001     -       (2,855
Total other income (expense), net     228       115       (3,284     343       (3,283
Loss before income tax expense     (1,853 )     (1,493     (2,895 )          (3,346 )     (3,625 )
Income tax expense     -       -       -       -       -  
Net loss   $ (1,853 )   $ (1,493   $ (2,895 )   $ (3,346 )   $ (3,625 )
Net loss per share – basic and diluted   $ (0.11 )   $ (0.09   $ (0.24 )   $ (0.20 )   $ (0.30 )
Weighted average common shares outstanding – basic and diluted     17,875,930       16,141,153       12,212,403       17,008,544       12,195,415  
Book value per share   $ 2.28     $ 2.53     $ (0.08   $ 2.28     $ (0.08


Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows (unaudited)

    Six Months Ended
December 31,
 
($ in thousands)   2025     2024  
Operating activities:            
Net loss   $ (3,346 )   $ (3,625 )
Adjustments to reconcile net loss to net cash used in operating activities:                
Amortization of deferred compensation     -       14  
Stock-based compensation expense     2,112       316  
Depreciation and amortization expense     210       202  
Amortization of discount on convertible notes     -       428  
Changes in fair value of derivative liabilities     -       2,855  
Changes in operating assets and liabilities:                
Accounts receivable     (38 )     (1,265
Prepaids and other current assets     (58 )     (114 )
Other assets     (8 )       -
Accounts payable     (177     (134 )
Accrued expenses and other current liabilities     239       (9
Net cash used in operating activities     (1,066 )     (1,332 )
Investing activities:                
Purchase of equipment     (241 )     (41 )
Net cash used in investing activities     (241 )     (41 )
Financing activities:                
Proceeds from stock option exercise     64       -  
Proceeds from stock warrant exercise     690       -  
Proceeds from convertible notes issuance     -       3,145  
Proceeds from public offering, net of offering costs     23,385       -  
Net cash provided by financing activities     24,139       3,145  
Net change in cash and cash equivalents, and certificate of deposit     22,832       1,772  
Cash and cash equivalents, and certificate of deposit, beginning of period     15,740       1,291  
Cash and cash equivalents, and certificate of deposit, end of period   $ 38,572     $ 3,063  
                 
Supplemental non-cash disclosures:                
Right of use asset - operating obtained in exchange for lease liability - operating    $ 274       -  


Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited)

    Three Months Ended     Six Months Ended  
($ in thousands, except per share data)   December 31,
2025
    September 30,
2025
    December 31,
2024
    December 31,
2025
    December 31,
2024
 
GAAP net loss   $ (1,853 )   $ (1,493   $ (2,895 )   $ (3,346 )   $ (3,625 )
Non-GAAP adjustments:                                        
Stock-based compensation - stock option     1,056       1,056       149       2,112       316  
Consulting and advisory - restricted stock award     -       -       7       -       14  
Amortization of discount on convertible notes     -       -       283       -       428  
Changes in fair value of derivative liabilities     -       -       3,001       -       2,855  
Total adjustments to GAAP net loss     1,056       1,056       3,440       2,112       3,613  
Non-GAAP net income (loss)   $ (797 )   $ (437   $ 545     $ (1,234 )   $ (12 )
Depreciation & amortization     108       102       102       210       202  
Interest income     (228 )     (115 )     -       (343 )     -  
Adjusted EBITDA   $ (917 )   $ (450   $ 647     $ (1,367   $ 190  
                                         
GAAP net loss per share – basic and diluted   $ (0.11 )   $ (0.09   $ (0.24 )   $ (0.20 )   $ (0.30 )
Non-GAAP adjustments     0.07       0.06       0.28       0.13       0.30  
Non-GAAP net income (loss) per share – basic and diluted   $ (0.04 )   $ (0.03   $ 0.04     $ (0.07 )   $ -  



Primary Logo